超越新生血管:氧诱导视网膜病变模型中的光反应缺陷
早产儿视网膜病变(ROP)传统上被视为视网膜血管疾病,但血管恢复后许多患者仍存在长期光反应缺陷。本综述总结了氧诱导视网膜病变(OIR)模型中不同视网膜细胞群的光反应缺陷,指出缺陷源于光感受器并向下游神经元传播,OIR模型可用于研究ROP神经元成分并指导治疗开发。
要点
- ROP患者血管恢复后仍可长期存在视网膜光反应缺陷。
- OIR模型中光反应缺陷起源于光感受器并向视网膜回路下游累积。
- OIR模型是研究ROP神经元成分和长期视力改善策略的有价值平台。
核心结论
- OIR模型可用于研究ROP中独立于血管异常的光反应缺陷,为改善长期视力提供平台。
研究设计与样本
- 叙述性综述,汇总OIR模型中不同视网膜细胞群光反应缺陷的现有证据。
主要发现
- 光反应缺陷起源于光感受器并沿下游视网膜神经元传播,导致视网膜回路累积性损伤。
临床怎么用
- 在ROP管理中除关注血管新生外,应重视神经元光反应缺陷的评估与靶向治疗研究。
局限性
- ROP中光反应缺陷的机制尚不清楚,限制了针对神经元成分的疗法开发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Retinopathy of prematurity (ROP) has traditionally been viewed as a retinal vascular disease. However, even after vascular recovery, many patients experience retinal light response deficits for years, possibly lifelong. Despite major treatment advances that target abnormal retinal neovascularization, ROP remains a major cause of vision loss in premature infants. The mouse and rat oxygen-induced retinopathy (OIR) models are widely used to study ROP and have been instrumental in developing anti-VEGF treatments for retinal neovascular diseases. In contrast, the mechanisms underlying retinal light response deficits in ROP remain poorly understood-and this limits the development of therapies targeting the neuronal component of ROP. This review summarizes current knowledge of retinal light response deficits in OIR across different retinal cell populations. Available evidence suggests that deficits originate in photoreceptors and propagate through downstream retinal neurons, resulting in cumulative impairment across the retinal circuit. By reviewing existing findings, discussing underlying mechanisms, and identifying key knowledge gaps, this review evaluates OIR as a valuable platform to investigate retinal light response deficits and to guide the development of strategies to improve long-term vision outcomes for patients with ROP.
引用
- Becker S. Beyond Neovascularization: Light Response Deficits in Oxygen-Induced Retinopathy Models. Invest Ophthalmol Vis Sci. 2026. PMID: 42714242. doi:10.1167/iovs.67.11.13
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。